After 156 banned drugs, 34 more multivitamins under review: Sources
December 12, 2025
  • Read Ecopy
  • Circulation
  • Advertise
  • Careers
  • About Us
  • Contact Us
Android AppiPhone AppArattai
Organiser
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
  • Editorial
  • International
  • Opinion
  • RSS @ 100
  • More
    • Op Sindoor
    • Analysis
    • Sports
    • Defence
    • Politics
    • Business
    • Economy
    • Culture
    • Special Report
    • Sci & Tech
    • Entertainment
    • G20
    • Azadi Ka Amrit Mahotsav
    • Vocal4Local
    • Web Stories
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
  • Subscribe
    • Subscribe Print Edition
    • Subscribe Ecopy
    • Read Ecopy
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
  • Editorial
  • International
  • Opinion
  • RSS @ 100
  • More
    • Op Sindoor
    • Analysis
    • Sports
    • Defence
    • Politics
    • Business
    • Economy
    • Culture
    • Special Report
    • Sci & Tech
    • Entertainment
    • G20
    • Azadi Ka Amrit Mahotsav
    • Vocal4Local
    • Web Stories
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
  • Subscribe
    • Subscribe Print Edition
    • Subscribe Ecopy
    • Read Ecopy
Organiser
  • Home
  • Bharat
  • World
  • Operation Sindoor
  • Editorial
  • Analysis
  • Opinion
  • Culture
  • Defence
  • International Edition
  • RSS @ 100
  • Magazine
  • Read Ecopy
Home Bharat

After 156 banned drugs, 34 more multivitamins under review: Sources

In the wake of banning 156 drugs, authorities are now focusing on 34 more multivitamins. Sources reveal that these products are undergoing detailed scrutiny to verify their safety and regulatory compliance. This intensified review highlights the commitment to safeguarding public health

WEBDESKWEBDESK
Sep 4, 2024, 11:00 pm IST
in Bharat, Health
Follow on Google News
Representative image

Representative image

FacebookTwitterWhatsAppTelegramEmail

Following the recent ban on 156 drugs, the Government of India is now considering banning 34 additional multivitamins, according to sources. “34 multivitamins are under evaluation based on reviews,” sources said.

The sources also mentioned that under new regulations, states can no longer approve drug combinations.

“Based on the recommendations of the DTAB sub-committee, the Union Government recently prohibited 156 Fixed-Dose Combinations (FDCs),” sources added.

“As per the first assessment report of the Professor Kokate committee, constituted by the Union Government to examine FDCs licensed by state authorities without the permission of the Drug Controller General of India (DCGI), several FDCs were declared irrational. However, these notifications were challenged in court, and the matter was referred to the DTAB,” sources said.

Sources indicated that these drugs are banned based on concerns about safety and efficacy.

The Indian Pharmaceutical Alliance (IPA) has endorsed the government’s decision. Sudarshan Jain, Secretary General of the IPA, told ANI, “This has been ongoing for many years, with committees such as the Kokate Committee and the Nilima Kshirsagar Committee reviewing the matter extensively. This is a right step taken in the interest of patients, considering all aspects.”

When asked about the impact on pharmaceutical companies, Jain said, “They have been given the opportunity to provide data supporting their products. Those with adequate supporting data will continue, while companies lacking such data will have to withdraw their products.”

The list of banned drugs includes medications used for hair treatments, antiparasitic purposes, skincare, and anti-allergic treatments. These medicines are fixed-dose combination (FDC) drugs, also known as cocktail drugs, which combine more than one drug into a single pill.

According to a Gazette notification issued by the government announcing the ban, “The matter was examined by an Expert Committee appointed by the Union Government, which reviewed the entire issue thoroughly and deemed these FDCs irrational. The Drugs Technical Advisory Board also examined these FDCs and recommended that there is no therapeutic justification for the ingredients contained in them, and they may pose risks to human beings.”

The notification further stated, “In the larger public interest, it is necessary to prohibit the manufacture, sale, or distribution of these FDCs under Section 26A of the Drugs and Cosmetics Act, 1940. Based on the recommendations of the Drugs Technical Advisory Board, the Central Government is satisfied that it is necessary and expedient in the public interest to prohibit the manufacture for sale, sale, and distribution for human use of the said drugs in the country.”

Among the banned combinations is the FDC of Amylase + Protease + Glucoamylase + Pectinase + Alpha Galactosidase + Lactase + Beta-Gluconase + Cellulase + Lipase + Bromelain + Xylanase + Hemicellulase + Malt diastase + Invertase + Papain, which has been prohibited with immediate effect. Mefenamic Acid + Paracetamol Injection is likely to pose a risk to human beings and is also prohibited.

Also Read: ICMR’s New TB Testing Technology: Affordable detection at just Rs 35

Additionally, Ergotamine tartrate + Caffeine + Paracetamol + Prochlorperazine maleate has also been prohibited with immediate effect.

Topics: Banned drugsMultivitaminsDrug Controller General of India
Share1TweetSendShareSend
✮ Subscribe Organiser YouTube Channel. ✮
✮ Join Organiser's WhatsApp channel for Nationalist views beyond the news. ✮
Previous News

Haryana Assembly Polls: BJP releases first list of 67 candidates; CM Saini to contest from Ladwa

Next News

Kerala: Sexual abuse charges continue to mar Malayalam film industry as Nivin Pauly faces allegations 

Related News

No Content Available
Load More

Comments

The comments posted here/below/in the given space are not on behalf of Organiser. The person posting the comment will be in sole ownership of its responsibility. According to the central government's IT rules, obscene or offensive statement made against a person, religion, community or nation is a punishable offense, and legal action would be taken against people who indulge in such activities.

Latest News

The Preah Vihear Temple on a cliff in the Dangrek mountains along the border of Cambodia-Thailand

Thailand-Cambodia conflict: UNESCO urges urgent protection of the Hindu temple & cultural heritage

Representative Image

Baloch woman critically injured in Kech as Pakistani forces accused of indiscriminate firing

Ambassador Harish Parvathaneni, India's Permanent Representative to the UN

India calls for “pragmatic engagement” with Taliban at UNSC meeting on Afghanistan

Hindu–Sikh Unity: The foundation of Punjab’s strength and stability

Muhammad Yunus, Chief Advisor of the Interim administration of Bangladesh

Unmasking Muhammad Yunus: Series of lies etched with corruption, plagiarism, shadow deals & ultimate thirst for power

Bhattacharya, IAS (Retd.),

Telangana: Retired IAS officer turns economics lecture into anti-Hindu tirade; FIR filed at IPE Hyderabad

The Tamil Community in Moreh

Tamil footprints on the Indo-Myanmar frontier: A civilisational saga from Rangoon to Moreh

Duff performance in front of Chennakeshava temple, Mangaluru cancelled after opposition from Hindu organisations

Karnataka: Performance of Duff in front of Chennakeshava temple cancelled due to opposition from Hindu organisations

Modi–Putin diplomacy triumphs as Congress drowns in its own confusion

Bangladesh national elections scheduled for February 12

Bangladesh elections on Feb 12; First since the topple of Hasina regime, Set to decide political course of the country

Load More
  • Privacy
  • Terms
  • Cookie Policy
  • Refund and Cancellation
  • Delivery and Shipping

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

  • Home
  • Search Organiser
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Africa
    • North America
    • South America
    • Europe
    • Australia
  • Editorial
  • Operation Sindoor
  • Opinion
  • Analysis
  • Defence
  • Culture
  • Sports
  • Business
  • RSS @ 100
  • Entertainment
  • More ..
    • Sci & Tech
    • Vocal4Local
    • Special Report
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Health
    • Politics
    • Law
    • Economy
    • Obituary
  • Subscribe Magazine
  • Read Ecopy
  • Advertise
  • Circulation
  • Careers
  • About Us
  • Contact Us
  • Policies & Terms
    • Privacy Policy
    • Cookie Policy
    • Refund and Cancellation
    • Terms of Use

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies